Ropes & Gray advised HotSpot Therapeutics on the deal. HotSpot Therapeutics announced an exclusive, worldwide collaboration and option to license agreement with AbbVie for HotSpot’s new class...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Dessert Holdings, while Katten Muchin Rosenman represented Dianne’s in the transaction. Dessert Holdings announced its acquisition of Dianne’s Fine Desserts, a provider...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Bain Capital Private Equity and Dessert Holdings, while Davis Graham & Stubbs advised Steven Charles on the deal. Dessert Holdings, North America’s...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Takeda Pharmaceutical Company Limited in the deal. Takeda Pharmaceutical Company Limited announced an exclusive collaboration and license agreement with JCR Pharmaceuticals Co.,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Adaptimmune in the deal. Adaptimmune signed its strategic collaboration with Roche Group’s Genentech Inc. to research, develop and commercialize cancer-target allogeneic T-cell...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Shape Therapeutics in the deal. Shape Therapeutics entered into a strategic research collaboration and license agreement with Roche worth up to $3...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised iTeos Therapeutics in the deal. iTeos Therapeutics closed a collaboration with global healthcare leader GSK to co-develop and co-commercialize an anti-TIGIT monoclonal...
You must be a Standard 1 Year member to access this content.
